Cargando…

Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout

BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yannan, Zhang, Huanzhen, Chang, Dong, Guo, Fuchuan, Pan, Hongzhi, Yang, Yuexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989453/
https://www.ncbi.nlm.nih.gov/pubmed/29871692
http://dx.doi.org/10.1186/s13075-018-1600-5
_version_ 1783329467188379648
author Zhang, Yannan
Zhang, Huanzhen
Chang, Dong
Guo, Fuchuan
Pan, Hongzhi
Yang, Yuexin
author_facet Zhang, Yannan
Zhang, Huanzhen
Chang, Dong
Guo, Fuchuan
Pan, Hongzhi
Yang, Yuexin
author_sort Zhang, Yannan
collection PubMed
description BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic profile of patients with asymptomatic hyperuricemia (HUA) and gout by using a metabolomics approach, and find potential pathophysiological mechanisms of and markers of predisposition to gout. METHODS: Serum samples were collected from 149 subjects, including 50 patients with HUA, 49 patients with gout and 50 healthy controls. (1)H nuclear magnetic resonance (NMR) spectroscopy combined with principal components analysis and orthogonal partial least squares-discriminant analysis were used to distinguish between samples from patients and healthy controls. Clinical measurements and pathway analysis were also performed to contribute to understanding of the metabolic change. RESULTS: By serum metabolic profiling, 21 metabolites including lipids and amino acids were significantly altered in patients with HUA or gout. The levels of identified biomarkers together with clinical data showed apparent alteration trends in patients with HUA or gout compared to healthy individuals. According to pathway analysis, three and five metabolic pathways were remarkably perturbed in patients with HUA or gout, respectively. These enriched pathways involve in lipid metabolism, carbohydrate metabolism, amino acids metabolism and energy metabolism. CONCLUSIONS: Taken together, we identified the biomarker signature for HUA and gout, which provides biochemical insights into the metabolic alteration, and identified a continuous progressive axis of development from HUA to gout. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1600-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5989453
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59894532018-06-21 Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout Zhang, Yannan Zhang, Huanzhen Chang, Dong Guo, Fuchuan Pan, Hongzhi Yang, Yuexin Arthritis Res Ther Research Article BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic profile of patients with asymptomatic hyperuricemia (HUA) and gout by using a metabolomics approach, and find potential pathophysiological mechanisms of and markers of predisposition to gout. METHODS: Serum samples were collected from 149 subjects, including 50 patients with HUA, 49 patients with gout and 50 healthy controls. (1)H nuclear magnetic resonance (NMR) spectroscopy combined with principal components analysis and orthogonal partial least squares-discriminant analysis were used to distinguish between samples from patients and healthy controls. Clinical measurements and pathway analysis were also performed to contribute to understanding of the metabolic change. RESULTS: By serum metabolic profiling, 21 metabolites including lipids and amino acids were significantly altered in patients with HUA or gout. The levels of identified biomarkers together with clinical data showed apparent alteration trends in patients with HUA or gout compared to healthy individuals. According to pathway analysis, three and five metabolic pathways were remarkably perturbed in patients with HUA or gout, respectively. These enriched pathways involve in lipid metabolism, carbohydrate metabolism, amino acids metabolism and energy metabolism. CONCLUSIONS: Taken together, we identified the biomarker signature for HUA and gout, which provides biochemical insights into the metabolic alteration, and identified a continuous progressive axis of development from HUA to gout. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1600-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-05 2018 /pmc/articles/PMC5989453/ /pubmed/29871692 http://dx.doi.org/10.1186/s13075-018-1600-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Yannan
Zhang, Huanzhen
Chang, Dong
Guo, Fuchuan
Pan, Hongzhi
Yang, Yuexin
Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title_full Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title_fullStr Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title_full_unstemmed Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title_short Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
title_sort metabolomics approach by (1)h nmr spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989453/
https://www.ncbi.nlm.nih.gov/pubmed/29871692
http://dx.doi.org/10.1186/s13075-018-1600-5
work_keys_str_mv AT zhangyannan metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout
AT zhanghuanzhen metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout
AT changdong metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout
AT guofuchuan metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout
AT panhongzhi metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout
AT yangyuexin metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout